Touyun Biotech Group Limited (HKG:1332)

Touyun Biotech Group Revenue

Touyun Biotech Group had revenue of 35.47M HKD in the half year ending June 30, 2026, a decrease of -25.92%. This brings the company's total for the last twelve months to 70.92M, down -14.81% year-over-year. In the year 2025, Touyun Biotech Group had annual revenue of 66.97M, down -32.76%. That makes Touyun Biotech Group the 37,866th largest company in the world by revenue and 2,300th in Hong Kong.

• Revenue (ttm): 70.92M
• Revenue Growth: -14.81%
• P/S Ratio: 5.91
• Revenue / Employee: 234.83K
• Employees: 302
• Market Cap: 418.84M

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Packaging Products 62.28M 86.6%
• Chlamydomonas Reinhardtii Products Business 9.67M 13.4%

By Geography

Chart

• Hong Kong and The PRC 20.95M 31.3%
• Switzerland 13.59M 20.3%
• Other Europe 11.65M 17.4%
• Netherlands 8.89M 13.3%
• Others 8.42M 12.6%
• North and South America 3.47M 5.2%

Fiscal year ended Dec 31, 2025 See the full Touyun Biotech Group breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	66.97M	-32.63M	-32.76%
Dec 31, 2024	99.60M	-99.04M	-49.86%
Dec 31, 2023	198.64M	-117.19M	-37.10%
Dec 31, 2022	315.83M	32.32M	11.40%
Dec 31, 2021	283.51M	76.72M	37.10%

Data Source: S&P Global Market Intelligence Last updated: Sep 16, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Nov 8, 2026

Data Sources Report a data error